Bio-Rad Droplet Digital PCR-Based Assays

Bio-Rad Laboratories has launched droplet digital PCR Genome Edit Detection assays, which can characterize edits generated by CRISPR-Cas9 or other genome editing tools. The assays use ddPCR technology which increases the signal-to-noise ratio, allowing users to quantify extremely rare edits, even those with frequencies of 0.5 percent and from as little as 5 nanograms of genomic DNA. Users can expect to obtain results within one day.


Children's Hospital Los Angeles OncoKids

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.